MedTrace Logo

Serum Nesfatin-1 and Human Cartilage Glycoprotein-39 Levels in Knee Osteoarthritis

NCT06254976 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2024-02-23

No results posted yet for this study

Summary

In this study, our objective was to assess the correlation between serum human cartilage glycoprotein-39 (YKL-40) and nesfatin-1 values, the patient's clinical condition, ultrasonographic cartilage thickness measurements, and the response to PRP treatment in knee osteoarthritis (OA)

Conditions

  • Osteoarthritis of Knee
  • Degenerative Osteoarthritis

Interventions

BEHAVIORAL

exercise

2 weeks of home exercise

BIOLOGICAL

intraarticular knee PRP injections

2 doses of intra-articular platelet rich plasma (PRP) injection, 1 week apart

Sponsors & Collaborators

  • Kayseri City Hospital

    lead OTHER_GOV

Principal Investigators

  • Havva Talay Çalış, Prof · Saglik Bilimleri Universitesi

  • Duygu Gökbelen Bilen · Saglik Bilimleri Universitesi

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
SEQUENTIAL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-06-01
Primary Completion
2023-06-01
Completion
2023-12-01

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06254976 on ClinicalTrials.gov